Year-over-year articles
PCI BIOTECH HOLDING ASA
19 crawlable comparisons of consecutive annual reports.
Full company analysis · Org.nr 991 036 393
Weaker earnings, cash halved-plus
Comparing Årsregnskap 2025 with 2024 for PCI BIOTECH HOLDING ASA. Revenue 0 NOK → 2.94m NOK. Net result -35.3k NOK → -42.29m NOK. Equity 43.99m NOK → 2.90m NOK.
Shrank 100% on revenue, slipped into loss, fresh owner capital
Comparing Årsregnskap 2024 with 2023 for PCI BIOTECH HOLDING ASA. Revenue 2.99m NOK → 0 NOK (-100.0%). Net result +435.0k NOK → -35.3k NOK. Equity 78.42m…
Shrank 37% on revenue, returned to profit, cash halved-plus
Comparing Årsregnskap 2023 with 2022 for PCI BIOTECH HOLDING ASA. Revenue 4.75m NOK → 2.99m NOK (-37.1%). Net result -467.24m NOK → +435.0k NOK. Equity…
Shrank 24% on revenue, weaker earnings, cash halved-plus
Comparing Årsregnskap 2022 with 2021 for PCI BIOTECH HOLDING ASA. Revenue 6.27m NOK → 4.75m NOK (-24.3%). Net result -154.91m NOK → -467.24m NOK. Equity…
Slipped into loss, cash halved-plus
Comparing Årsregnskap 2021 with 2020 for PCI BIOTECH HOLDING ASA. Revenue 0 NOK → 6.27m NOK. Net result +429 NOK → -154.91m NOK. Equity 686.5k NOK → 544.57m…
Weaker earnings
Comparing Årsregnskap 2020 with 2019 for PCI BIOTECH HOLDING ASA. Revenue 0 NOK → 0 NOK (0.0%). Net result +179.0k NOK → +429 NOK. Equity 673.5k NOK →…
Shrank 100% on revenue
Comparing Årsregnskap 2019 with 2018 for PCI BIOTECH HOLDING ASA. Revenue 9.59m NOK → 0 NOK (-100.0%). Equity 669.7k NOK → 673.5k NOK.
Fresh owner capital
Comparing Årsregnskap 2018 with 2017 for PCI BIOTECH HOLDING ASA. Revenue 0 NOK → 9.59m NOK. Equity 329.3k NOK → 669.7k NOK.
Weaker earnings, cash halved-plus
Comparing Årsregnskap 2017 with 2016 for PCI BIOTECH HOLDING ASA. Revenue 0 NOK → 0 NOK (0.0%). Net result +146.52m NOK → +34.15m NOK. Equity 223.57m NOK →…
Returned to profit, cash halved-plus
Comparing Årsregnskap 2016 with 2015 for PCI BIOTECH HOLDING ASA. Net result -152.71m NOK → +146.52m NOK. Equity 76.06m NOK → 223.57m NOK.
Another loss-making year
Comparing Årsregnskap 2015 with 2013 for PCI BIOTECH HOLDING ASA.
Shrank 100% on revenue
Comparing Årsregnskap 2013 with 2012 for PCI BIOTECH HOLDING ASA. Revenue 6.76m NOK → 6 681 NOK (-99.9%).
Mixed movements in the accounts
Comparing Årsregnskap 2012 with 2011 for PCI BIOTECH HOLDING ASA. Revenue 0 NOK → 6.76m NOK. Equity 188.2k NOK → 187.62m NOK.
Shrank 100% on revenue, cash halved-plus, fresh owner capital
Comparing Årsregnskap 2011 with 2010 for PCI BIOTECH HOLDING ASA. Revenue 10.44m NOK → 0 NOK (-100.0%). Equity 187.31m NOK → 188.2k NOK.
Grew 21% on revenue
Comparing Årsregnskap 2010 with 2009 for PCI BIOTECH HOLDING ASA. Revenue 8.61m NOK → 10.44m NOK (+21.3%). Net result -15.02m NOK → -13.94m NOK. Equity…
Grew 17% on revenue, weaker earnings, cash halved-plus
Comparing Årsregnskap 2009 with 2008 for PCI BIOTECH HOLDING ASA. Revenue 7.37m NOK → 8.61m NOK (+16.9%). Net result -11.38m NOK → -15.02m NOK.
Slipped into loss, fresh owner capital
Comparing Årsregnskap 2008 with 2007 for PCI BIOTECH HOLDING ASA. Net result +412 NOK → -11.38m NOK.
Fresh owner capital
Comparing Årsregnskap 2007 with 2006 for PCI BIOTECH HOLDING ASA. Equity 7 NOK → 1000.41bn NOK.
First published accounts
First year in the published series for PCI BIOTECH HOLDING ASA (2006). No prior-year comparative in this dataset.